BAVARIAN NORDIC A/S (BV3.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:BV3 • DK0015998017

26.12 EUR
-0.14 (-0.53%)
Last: Feb 5, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

BV3 gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 81 industry peers in the Biotechnology industry. While BV3 has a great health rating, its profitability is only average at the moment. BV3 may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make BV3 a good candidate for value investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year BV3 was profitable.
  • In the past year BV3 had a positive cash flow from operations.
  • In multiple years BV3 reported negative net income over the last 5 years.
  • BV3 had a positive operating cash flow in 4 of the past 5 years.
BV3.DE Yearly Net Income VS EBIT VS OCF VS FCFBV3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 16.13%, BV3 belongs to the top of the industry, outperforming 91.36% of the companies in the same industry.
  • BV3 has a better Return On Equity (18.58%) than 86.42% of its industry peers.
  • With an excellent Return On Invested Capital value of 13.14%, BV3 belongs to the best of the industry, outperforming 90.12% of the companies in the same industry.
Industry RankSector Rank
ROA 16.13%
ROE 18.58%
ROIC 13.14%
ROA(3y)4.78%
ROA(5y)2.73%
ROE(3y)6.02%
ROE(5y)3.49%
ROIC(3y)N/A
ROIC(5y)N/A
BV3.DE Yearly ROA, ROE, ROICBV3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • With an excellent Profit Margin value of 35.50%, BV3 belongs to the best of the industry, outperforming 91.36% of the companies in the same industry.
  • The Operating Margin of BV3 (36.21%) is better than 91.36% of its industry peers.
  • Looking at the Gross Margin, with a value of 54.33%, BV3 is in line with its industry, outperforming 49.38% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BV3 has remained more or less at the same level.
Industry RankSector Rank
OM 36.21%
PM (TTM) 35.5%
GM 54.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.91%
GM growth 5Y1.2%
BV3.DE Yearly Profit, Operating, Gross MarginsBV3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BV3 is still creating some value.
  • BV3 has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BV3 has more shares outstanding
  • BV3 has a better debt/assets ratio than last year.
BV3.DE Yearly Shares OutstandingBV3.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
BV3.DE Yearly Total Debt VS Total AssetsBV3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

  • BV3 has an Altman-Z score of 7.17. This indicates that BV3 is financially healthy and has little risk of bankruptcy at the moment.
  • BV3 has a better Altman-Z score (7.17) than 82.72% of its industry peers.
  • BV3 has a debt to FCF ratio of 0.10. This is a very positive value and a sign of high solvency as it would only need 0.10 years to pay back of all of its debts.
  • BV3's Debt to FCF ratio of 0.10 is amongst the best of the industry. BV3 outperforms 95.06% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that BV3 is not too dependend on debt financing.
  • BV3 has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. BV3 outperforms 82.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.1
Altman-Z 7.17
ROIC/WACC1.66
WACC7.92%
BV3.DE Yearly LT Debt VS Equity VS FCFBV3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

  • BV3 has a Current Ratio of 3.84. This indicates that BV3 is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 3.84, BV3 is doing good in the industry, outperforming 70.37% of the companies in the same industry.
  • A Quick Ratio of 2.43 indicates that BV3 has no problem at all paying its short term obligations.
  • The Quick ratio of BV3 (2.43) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 3.84
Quick Ratio 2.43
BV3.DE Yearly Current Assets VS Current LiabilitesBV3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 39.44% over the past year.
  • BV3 shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.47%.
  • Measured over the past years, BV3 shows a very strong growth in Revenue. The Revenue has been growing by 53.88% on average per year.
EPS 1Y (TTM)39.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%414.42%
Revenue 1Y (TTM)13.47%
Revenue growth 3Y44.42%
Revenue growth 5Y53.88%
Sales Q2Q%32.58%

3.2 Future

  • Based on estimates for the next years, BV3 will show a small growth in Earnings Per Share. The EPS will grow by 4.41% on average per year.
  • BV3 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.09% yearly.
EPS Next Y54.87%
EPS Next 2Y-4.62%
EPS Next 3Y1.7%
EPS Next 5Y4.41%
Revenue Next Year9.45%
Revenue Next 2Y-0.91%
Revenue Next 3Y-0.48%
Revenue Next 5Y3.09%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BV3.DE Yearly Revenue VS EstimatesBV3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
BV3.DE Yearly EPS VS EstimatesBV3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5 10 15

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.51, the valuation of BV3 can be described as reasonable.
  • 96.30% of the companies in the same industry are more expensive than BV3, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of BV3 to the average of the S&P500 Index (27.93), we can say BV3 is valued rather cheaply.
  • The Price/Forward Earnings ratio is 20.47, which indicates a rather expensive current valuation of BV3.
  • Based on the Price/Forward Earnings ratio, BV3 is valued cheaply inside the industry as 83.95% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.77, BV3 is valued a bit cheaper.
Industry RankSector Rank
PE 11.51
Fwd PE 20.47
BV3.DE Price Earnings VS Forward Price EarningsBV3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, BV3 is valued cheaper than 95.06% of the companies in the same industry.
  • 96.30% of the companies in the same industry are more expensive than BV3, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.04
EV/EBITDA 3.67
BV3.DE Per share dataBV3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • BV3's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of BV3 may justify a higher PE ratio.
PEG (NY)0.21
PEG (5Y)N/A
EPS Next 2Y-4.62%
EPS Next 3Y1.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • BV3 does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BAVARIAN NORDIC A/S

FRA:BV3 (2/5/2026, 7:00:00 PM)

26.12

-0.14 (-0.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-14
Earnings (Next)03-12
Inst Owners28.69%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap2.07B
Revenue(TTM)6.89B
Net Income(TTM)2.44B
Analysts84.44
Price Target34.14 (30.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.03%
PT rev (3m)-29.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-32.84%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.52%
Valuation
Industry RankSector Rank
PE 11.51
Fwd PE 20.47
P/S 2.24
P/FCF 12.04
P/OCF 4.93
P/B 1.17
P/tB 2.17
EV/EBITDA 3.67
EPS(TTM)2.27
EY8.69%
EPS(NY)1.28
Fwd EY4.88%
FCF(TTM)2.17
FCFY8.3%
OCF(TTM)5.29
OCFY20.27%
SpS11.64
BVpS22.24
TBVpS12.06
PEG (NY)0.21
PEG (5Y)N/A
Graham Number33.7
Profitability
Industry RankSector Rank
ROA 16.13%
ROE 18.58%
ROCE 18.66%
ROIC 13.14%
ROICexc 16.9%
ROICexgc 40.21%
OM 36.21%
PM (TTM) 35.5%
GM 54.33%
FCFM 18.64%
ROA(3y)4.78%
ROA(5y)2.73%
ROE(3y)6.02%
ROE(5y)3.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y17.91%
GM growth 5Y1.2%
F-Score8
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.1
Debt/EBITDA 0.03
Cap/Depr 262.4%
Cap/Sales 26.84%
Interest Coverage 81.71
Cash Conversion 97.94%
Profit Quality 52.5%
Current Ratio 3.84
Quick Ratio 2.43
Altman-Z 7.17
F-Score8
WACC7.92%
ROIC/WACC1.66
Cap/Depr(3y)229.46%
Cap/Depr(5y)231.44%
Cap/Sales(3y)29.07%
Cap/Sales(5y)36.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%414.42%
EPS Next Y54.87%
EPS Next 2Y-4.62%
EPS Next 3Y1.7%
EPS Next 5Y4.41%
Revenue 1Y (TTM)13.47%
Revenue growth 3Y44.42%
Revenue growth 5Y53.88%
Sales Q2Q%32.58%
Revenue Next Year9.45%
Revenue Next 2Y-0.91%
Revenue Next 3Y-0.48%
Revenue Next 5Y3.09%
EBIT growth 1Y125.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year111.77%
EBIT Next 3Y18.67%
EBIT Next 5Y19.09%
FCF growth 1Y262.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y316.96%
OCF growth 3YN/A
OCF growth 5YN/A

BAVARIAN NORDIC A/S / BV3.DE FAQ

Can you provide the ChartMill fundamental rating for BAVARIAN NORDIC A/S?

ChartMill assigns a fundamental rating of 6 / 10 to BV3.DE.


What is the valuation status of BAVARIAN NORDIC A/S (BV3.DE) stock?

ChartMill assigns a valuation rating of 8 / 10 to BAVARIAN NORDIC A/S (BV3.DE). This can be considered as Undervalued.


How profitable is BAVARIAN NORDIC A/S (BV3.DE) stock?

BAVARIAN NORDIC A/S (BV3.DE) has a profitability rating of 6 / 10.


What are the PE and PB ratios of BAVARIAN NORDIC A/S (BV3.DE) stock?

The Price/Earnings (PE) ratio for BAVARIAN NORDIC A/S (BV3.DE) is 11.51 and the Price/Book (PB) ratio is 1.17.


What is the financial health of BAVARIAN NORDIC A/S (BV3.DE) stock?

The financial health rating of BAVARIAN NORDIC A/S (BV3.DE) is 8 / 10.